Company intelligence / Profile preview
KCC Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
KCC Pharmaceuticals is an established Nigerian pharmaceutical manufacturer with over two decades of experience. It focuses on producing high-quality generic medicines for both human and animal use. Its portfolio includes analgesics, anti-malarials, vitamins, antibiotics, corticosteroids and more. The company emphasizes quality assurance and compliance with cGMP standards but does not appear to have novel drug candidates in clinical trials at this time.
- Therapeutic areas
- Metabolic DisordersNeurologyPulmonologyInfectious DiseasesHematologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on KCC Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KCC Pharmaceuticals.